Prospective Sample Collection for Cancer of Bladder
NCT03973671 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2024-03-28
Summary
The goal of the Flemish Databank for Urothelial Cancer is to collect clinical and pathological data of patients treated for urothelial cancer (UC).
Conditions
- Urinary Bladder Neoplasms
Sponsors & Collaborators
-
KU Leuven
collaborator OTHER -
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Principal Investigators
-
Steven Joniau, MD, PhD · Assistant Professor
-
Frank Van Der Aa, MD, PhD · Assistant Professor
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-29
- Primary Completion
- 2027-05-31
- Completion
- 2032-05-31
Countries
- Belgium
Study Locations
More Related Trials
-
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
NCT02379429 ·Status: RECRUITING
-
Follow-Up of Bladder Cancer Patients From the New England Study of Environment and Health
NCT00776178 ·Status: COMPLETED
-
Basal Tumours in Bladder Cancer, Response to chemoTherapy
NCT04089748 ·Status: COMPLETED
-
Prognostic Performance of a Chemogram in Patients With Bladder Cancer.
NCT06403202 ·Status: RECRUITING
-
The Cxbladder Rule-out of Recurrent Urothelial Carcinoma
NCT03673202 ·Status: UNKNOWN
-
Olfactive Detection of Urothelial Carcinoma by Sniffer Dogs
NCT07334314 ·Status: RECRUITING
-
Incidence of Expression of Tumor Antigens in Cancer Tissue From Patients With Pathologically Demonstrated Bladder Cancer
NCT01706185 ·Status: COMPLETED
-
Confocal Laser Endomicroscopy in the Lower Urinary Tract
NCT03013894 ·Status: COMPLETED
-
Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.
NCT06167356 ·Status: RECRUITING
-
UroX Biomarker Bladder Cancer Study
NCT03973307 ·Status: UNKNOWN
-
Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging
NCT02462239 ·Status: COMPLETED ·Phase: NA
-
Bladder Bank (a Prospective Banking Study)
NCT06109857 ·Status: RECRUITING
-
Expression of MCM5 in Urine in Patients With Urothelial Cancers
NCT03796299 ·Status: UNKNOWN
-
CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma
NCT03013920 ·Status: COMPLETED
-
Prognostic Biomarkers in Patients With Urothelial Carcinoma
NCT04872036 ·Status: COMPLETED
-
Patient-reported Outcomes in Bladder Cancer
NCT03584659 ·Status: COMPLETED ·Phase: NA
-
Cost-Effectiveness in Bladder Cancer
NCT00126958 ·Status: UNKNOWN
-
Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging Paradigm
NCT05779631 ·Status: RECRUITING ·Phase: NA
-
Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder
NCT02745301 ·Status: COMPLETED
-
To Detect the Sensitivity of the UroMark Assay
NCT02781428 ·Status: COMPLETED
-
Prospective and Multicenter Italian Registry of Locally Advanced-Metastatic Urothelial Carcinoma
NCT06235268 ·Status: RECRUITING
-
Urine Cytology and Utility in Bladder Recurrence
NCT00971256 ·Status: COMPLETED
-
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
NCT03413982 ·Status: RECRUITING
-
Cystoscopic Imaging Collection and Enhancement pROject
NCT02427321 ·Status: COMPLETED
-
Detection of Disease in the Upper Tract
NCT05349812 ·Status: WITHDRAWN